BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36214438)

  • 1. Stachys lavandulifolia Vahl. exhibits promising in vitro and in vivo antileishmanial activity against Leishmania major infection.
    Alanazi AD; Albalawi AE; Almohammed HI; Shater AF
    Trop Biomed; 2022 Sep; 39(3):412-420. PubMed ID: 36214438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent In Vitro and In Vivo Effects of
    Alanazi AD; Majeed QAH; Alnomasy SF; Almohammed HI
    Trop Med Infect Dis; 2023 Jul; 8(7):. PubMed ID: 37505651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis.
    Badirzadeh A; Heidari-Kharaji M; Fallah-Omrani V; Dabiri H; Araghi A; Salimi Chirani A
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007843. PubMed ID: 31929528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fe3O4
    Albalawi AE; Khalaf AK; Alyousif MS; Alanazi AD; Baharvand P; Shakibaie M; Mahmoudvand H
    Biomed Pharmacother; 2021 Jul; 139():111566. PubMed ID: 33839494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileishmanial, cellular mechanisms, and cytotoxic effects of green synthesized zinc nanoparticles alone and in combined with glucantime against Leishmania major infection.
    Ghasemian Yadegari J; Khudair Khalaf A; Ezzatkhah F; Shakibaie M; Mohammadi HR; Mahmoudvand H
    Biomed Pharmacother; 2023 Aug; 164():114984. PubMed ID: 37321058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileishmanial effects, cellular mechanisms, and cytotoxicity of Elettaria cardamomum essential oil against Leishmania major infection.
    Majeed QA; Alshammari A; Alanazi AD
    Trop Biomed; 2023 Jun; 40(2):259-265. PubMed ID: 37650415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
    Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
    J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low doses of 3-phenyl-lawsone or meglumine antimoniate delivery by tattooing route are successful in reducing parasite load in cutaneous lesions of
    Meira RMV; Gomes SLDS; Schaeffer E; Da Silva T; Brito ACS; Siqueira LM; Inácio JD; Almeida-Amaral EE; Da-Cruz AM; Bezerra-Paiva M; Neves RH; Rodrigues LS; Dutra PML; Costa PRR; da Silva AJM; Da-Silva SAG
    Front Cell Infect Microbiol; 2023; 13():1025359. PubMed ID: 36743305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
    Moosavian SA; Fallah M; Jaafari MR
    Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmanicidal potentials of
    Sharifi F; Sharififar F; Pournamdari M; Ansari M; Tavakoli Oliaee R; Bamorovat M; Khosravi A; Keyhani AR; Salarkia E; Mortazaeizdeh A; Dabiri S; Khamesipour A; Sharifi I
    J Med Microbiol; 2021 Jun; 70(6):. PubMed ID: 34115583
    [No Abstract]   [Full Text] [Related]  

  • 11. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meglumine antımoniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect.
    Abamor ES; Allahverdiyev AM; Bagirova M; Rafailovich M
    Acta Trop; 2017 May; 169():30-42. PubMed ID: 28111133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the
    Azadi R; Alipour-Talesh G; Yazdanpanah MJ; Alavizadeh SH; Maleki M; Banihashemi M; Jaafari MR
    J Vector Borne Dis; 2020; 57(1):78-84. PubMed ID: 33818460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946.
    Rahimi S; Rafinejad J; Akhavan AA; Ahmadkhaniha R; Bakhtiyari M; Khamesipour A; Akbarzadeh K
    Parasit Vectors; 2023 Feb; 16(1):72. PubMed ID: 36797798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileishmanial, antioxidant, and cytotoxic activities of Quercus infectoria Olivier extract.
    Kheirandish F; Delfan B; Mahmoudvand H; Moradi N; Ezatpour B; Ebrahimzadeh F; Rashidipour M
    Biomed Pharmacother; 2016 Aug; 82():208-15. PubMed ID: 27470357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico and in vitro antileishmanial effects of gamma-terpinene: Multifunctional modes of action.
    Nooshadokht M; Mirzaei M; Sharifi I; Sharifi F; Lashkari M; Amirheidari B
    Chem Biol Interact; 2022 Jul; 361():109957. PubMed ID: 35472413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo host and parasite response to antileishmanial drugs and immunomodulators.
    Gonzalez-Fajardo L; Fernández OL; McMahon-Pratt D; Saravia NG
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003820. PubMed ID: 26024228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of leishmanicidal activity and cytotoxicity of Ricinus communis and Azadirachta indica extracts from western Kenya: in vitro and in vivo assays.
    Jumba BN; Anjili CO; Makwali J; Ingonga J; Nyamao R; Marango S; Choge JK; Khayeka-Wandabwa C
    BMC Res Notes; 2015 Nov; 8():650. PubMed ID: 26541197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
    Bemani E; Oryan A; Bahrami S
    Exp Parasitol; 2019 Oct; 205():107747. PubMed ID: 31442454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.